PhIP-Seq
From Wikipedia, the free encyclopedia
This article needs additional citations for verification . Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "PhIP-Seq" – news · newspapers · books · scholar · JSTOR (November 2017) (Learn how and when to remove this message)
Find sources: "PhIP-Seq" – news · newspapers · books · scholar · JSTOR (November 2017) (Learn how and when to remove this message)
Phage immunoprecipitation sequencing (PhIP-Seq) is method that combines barcoded DNA high-throughput sequencing and proteomics to determine the levels of binding of antibodies to epitopes. It has been used to study the autoantibody repertoire of autoimmune diseases like multiple sclerosis, type 2 diabetes and rheumatoid arthritis.[1] [2]
References
[edit ]- ^ Larman, H; et al. (2011). "Autoantigen discovery with a synthetic human peptidome". Nature Biotechnology. 29 (6): 535–541. doi:10.1038/nbt.1856. PMC 4169279 . PMID 21602805.
- ^ Larman, H; et al. (June 2013). "PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis". Journal of Autoimmunity. 43: 1–9. doi:10.1016/j.jaut.2013年01月01日3. PMC 3677742 . PMID 23497938.
Retrieved from "https://en.wikipedia.org/w/index.php?title=PhIP-Seq&oldid=1150501203"